projects
|
title
|
type of...
|
start
|
status
|
|
| |
|
Protocol SAKK 11/16: Personalized and cell-...
|
clinical studies
|
2020
|
scheduled
|
|
|
A Randomized, Double-blind, Adaptive, Phase...
|
clinical studies
|
2020
|
ongoing - rec...
|
|
|
Trial: SAKK 66/17 Intratumoral injection of...
|
clinical studies
|
2020
|
ongoing - rec...
|
|
|
Predictive markers for checkpoint-based imm...
|
fundamental r...
|
2020
|
ongoing - rec...
|
|
|
Phase 1/2a Study of BMS-986253 in Combinati...
|
clinical studies
|
2019
|
ongoing - rec...
|
|
|
Open label, non-randomized, Phase IB study ...
|
clinical studies
|
2019
|
scheduled
|
|
|
A phase I/Ib, open-label, multi-center dose...
|
clinical studies
|
2019
|
ongoing - rec...
|
|
|
SAKK 41/16: Neoadjuvant treatment with Rego...
|
clinical studies
|
2017
|
ongoing - rec...
|
|
|
A Phase 2, multi-center, open label study o...
|
clinical studies
|
2017
|
ongoing - rec...
|
|
|
A Phase 1/2a Dose Escalation and Cohort Exp...
|
clinical studies
|
2016
|
automatically...
|
|
|
An open-label Phase 1/2a study of BAL101553...
|
clinical studies
|
2016
|
ongoing - rec...
|
|
|
PhenoTox: Hunting the missing heritability ...
|
clinical studies
|
2016
|
ongoing - rec...
|
|
|
Predictive and prognostic value of integrat...
|
fundamental r...
|
2015
|
automatically...
|
|
|
Cachexia and Toxicity: cachexia-based dosin...
|
clinical studies
|
2014
|
automatically...
|
|
|
MP0250; A phase I multi-centre, open-label,...
|
clinical studies
|
2014
|
automatically...
|
|
|
LDE225 in combination with Paclitaxel in pa...
|
clinical studies
|
2013
|
automatically...
|
|
|
A phase III, multicenter, randomized, open-...
|
clinical studies
|
2013
|
automatically...
|
|
|
A Phase Ib/II, open-label, multicenter stud...
|
clinical studies
|
2013
|
automatically...
|
|
| |
page
1
of
2
additional links & downloads
